Search
Bright Minds Biosciences Inc
DRUGAdd to Watchlist
73.260USD
-1.370-1.84%
Close 07-31 16:00（ET）Quotes delayed by 15 min
721.85MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
7
analysts
Buy
Current Rating
148.557
Target Price
+102.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Bright Minds Biosciences Inc
DRUG
7
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Bright Minds Biosciences Inc's price target?
Analysts forecast that Bright Minds Biosciences Inc's price target is USD 80.00, with the highest forecast at USD 93.00 and the lowest forecast at USD 72.00.
How have Bright Minds Biosciences IncDRUG's recent earnings per share performed?
The market expectation was USD -0.78, while Bright Minds Biosciences IncDRUG's earnings per share (EPS) for the previous quarter was USD -0.71. EPS for the next quarter is expected at USD -1.25.
What is the analyst rating for Bright Minds Biosciences Inc?
Based on the ratings of Bright Minds Biosciences Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.